×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder
Become an Incathlab member and receive full access to its content!
You must be an Incathlab member to access videos without any restrictions. Register for free in one minute and access all services provided by Incathlab.You will also be able to log into Incathlab from your Facebook or twitter account by clicking on login on the top-right corner of Incathlab website.
Registration Login
Registration Login
16554 views
Case summary
Patient: male 77 y
Dyspnea and angina since several months
NSTEMI 26.11.16
3 vessels disease: several stenosis LAD, CX and RCA
culprit lesion LAD (with thrombus)
CTO IM branch und PD of RCA
Syntax score: 28
LVEF: 45%
Inferior and apikal akinesia
No valvular heart disease
Renal function: eGFR = 85 ml/min/1.73m2
CVRF: aHT, dysplidemia
How to treat this patient?
Syntax score: 28
EuroSCORE II: 2.2
STS-score: 1.2 for mortality
9.4 for morbiditiy and mortality
Proposed treatment: CABG, but patient refused
Todays planned procedures:
PCI of the LAD and diagonal branch
Ev. RCX PCI
Protocol
OptiRAY® (Ioversol)
Concentration 300 mgI/mL
Flow rate: 3.5 mL/ s
Volume: 112 mL
Total exposure : 0.8 Gy
Exposure time: 27 minutes
15 images / s low dose Philips
57 images mostly fluoro
Shooting date : 2016-11-03
Last update : 2021-06-09
Last update : 2021-06-09
OptiRAY® / Guerbet
Optiray® contrast agent is lower osmolar, lower viscosity and nonionic.
Join the Discussion
Suggestions
Tuesday, April 23rd 2024 from 05pm to 06:15pm (GMT+2)
Honolulu : Tuesday, April 23rd 2024 from 05am to 06:15am (GMT+2)
San Francisco : Tuesday, April 23rd 2024 from 08am to 09:15am (GMT+2)
New York : Tuesday, April 23rd 2024 from 11am to 12:15pm (GMT+2)
Buenos Aires : Tuesday, April 23rd 2024 from 12pm to 01:15pm (GMT+2)
Reykjavik : Tuesday, April 23rd 2024 from 03pm to 04:15pm (GMT+2)
London / Dublin : Tuesday, April 23rd 2024 from 04pm to 05:15pm (GMT+2)
Paris / Berlin : Tuesday, April 23rd 2024 from 05pm to 06:15pm (GMT+2)
Istanbul : Tuesday, April 23rd 2024 from 06pm to 07:15pm (GMT+2)
Moscou / Dubaï : Tuesday, April 23rd 2024 from 07pm to 08:15pm (GMT+2)
Bangkok : Tuesday, April 23rd 2024 from 10pm to 11:15pm (GMT+2)
Shanghai : Tuesday, April 23rd 2024 from 11pm to 12:15am (GMT+2)
Tokyo : Wednesday, April 24th 2024 from 12am to 01:15am (GMT+2)
Sydney : Wednesday, April 24th 2024 from 02am to 03:15am (GMT+2)
Wellington : Wednesday, April 24th 2024 from 04am to 05:15am (GMT+2)
San Francisco : Tuesday, April 23rd 2024 from 08am to 09:15am (GMT+2)
New York : Tuesday, April 23rd 2024 from 11am to 12:15pm (GMT+2)
Buenos Aires : Tuesday, April 23rd 2024 from 12pm to 01:15pm (GMT+2)
Reykjavik : Tuesday, April 23rd 2024 from 03pm to 04:15pm (GMT+2)
London / Dublin : Tuesday, April 23rd 2024 from 04pm to 05:15pm (GMT+2)
Paris / Berlin : Tuesday, April 23rd 2024 from 05pm to 06:15pm (GMT+2)
Istanbul : Tuesday, April 23rd 2024 from 06pm to 07:15pm (GMT+2)
Moscou / Dubaï : Tuesday, April 23rd 2024 from 07pm to 08:15pm (GMT+2)
Bangkok : Tuesday, April 23rd 2024 from 10pm to 11:15pm (GMT+2)
Shanghai : Tuesday, April 23rd 2024 from 11pm to 12:15am (GMT+2)
Tokyo : Wednesday, April 24th 2024 from 12am to 01:15am (GMT+2)
Sydney : Wednesday, April 24th 2024 from 02am to 03:15am (GMT+2)
Wellington : Wednesday, April 24th 2024 from 04am to 05:15am (GMT+2)
From Access to Closure through Treatment:
How to Maximize Outcomes while Minimizing Impact
Share
Wednesday, May 22nd 2024 from 03pm to 04pm (GMT+2)
Honolulu : Wednesday, May 22nd 2024 from 03am to 04am (GMT+2)
San Francisco : Wednesday, May 22nd 2024 from 06am to 07am (GMT+2)
New York : Wednesday, May 22nd 2024 from 09am to 10am (GMT+2)
Buenos Aires : Wednesday, May 22nd 2024 from 10am to 11am (GMT+2)
Reykjavik : Wednesday, May 22nd 2024 from 01pm to 02pm (GMT+2)
London / Dublin : Wednesday, May 22nd 2024 from 02pm to 03pm (GMT+2)
Paris / Berlin : Wednesday, May 22nd 2024 from 03pm to 04pm (GMT+2)
Istanbul : Wednesday, May 22nd 2024 from 04pm to 05pm (GMT+2)
Moscou / Dubaï : Wednesday, May 22nd 2024 from 05pm to 06pm (GMT+2)
Bangkok : Wednesday, May 22nd 2024 from 08pm to 09pm (GMT+2)
Shanghai : Wednesday, May 22nd 2024 from 09pm to 10pm (GMT+2)
Tokyo : Wednesday, May 22nd 2024 from 10pm to 11pm (GMT+2)
Sydney : Thursday, May 23rd 2024 from 12am to 01am (GMT+2)
Wellington : Thursday, May 23rd 2024 from 02am to 03am (GMT+2)
San Francisco : Wednesday, May 22nd 2024 from 06am to 07am (GMT+2)
New York : Wednesday, May 22nd 2024 from 09am to 10am (GMT+2)
Buenos Aires : Wednesday, May 22nd 2024 from 10am to 11am (GMT+2)
Reykjavik : Wednesday, May 22nd 2024 from 01pm to 02pm (GMT+2)
London / Dublin : Wednesday, May 22nd 2024 from 02pm to 03pm (GMT+2)
Paris / Berlin : Wednesday, May 22nd 2024 from 03pm to 04pm (GMT+2)
Istanbul : Wednesday, May 22nd 2024 from 04pm to 05pm (GMT+2)
Moscou / Dubaï : Wednesday, May 22nd 2024 from 05pm to 06pm (GMT+2)
Bangkok : Wednesday, May 22nd 2024 from 08pm to 09pm (GMT+2)
Shanghai : Wednesday, May 22nd 2024 from 09pm to 10pm (GMT+2)
Tokyo : Wednesday, May 22nd 2024 from 10pm to 11pm (GMT+2)
Sydney : Thursday, May 23rd 2024 from 12am to 01am (GMT+2)
Wellington : Thursday, May 23rd 2024 from 02am to 03am (GMT+2)
DanGER shock trial results and the significance to reduce adverse events
Share
May 2017
Honolulu : Tuesday, May 16th 2017 from 10:30pm to 11:30pm (GMT+2)
San Francisco : Wednesday, May 17th 2017 from 01:30am to 02:30am (GMT+2)
New York : Wednesday, May 17th 2017 from 04:30am to 05:30am (GMT+2)
Buenos Aires : Wednesday, May 17th 2017 from 05:30am to 06:30am (GMT+2)
Reykjavik : Wednesday, May 17th 2017 from 08:30am to 09:30am (GMT+2)
London / Dublin : Wednesday, May 17th 2017 from 09:30am to 10:30am (GMT+2)
Paris / Berlin : Wednesday, May 17th 2017 from 10:30am to 11:30am (GMT+2)
Istanbul : Wednesday, May 17th 2017 from 11:30am to 12:30pm (GMT+2)
Moscou / Dubaï : Wednesday, May 17th 2017 from 12:30pm to 01:30pm (GMT+2)
Bangkok : Wednesday, May 17th 2017 from 03:30pm to 04:30pm (GMT+2)
Shanghai : Wednesday, May 17th 2017 from 04:30pm to 05:30pm (GMT+2)
Tokyo : Wednesday, May 17th 2017 from 05:30pm to 06:30pm (GMT+2)
Sydney : Wednesday, May 17th 2017 from 07:30pm to 08:30pm (GMT+2)
Wellington : Wednesday, May 17th 2017 from 09:30pm to 10:30pm (GMT+2)
San Francisco : Wednesday, May 17th 2017 from 01:30am to 02:30am (GMT+2)
New York : Wednesday, May 17th 2017 from 04:30am to 05:30am (GMT+2)
Buenos Aires : Wednesday, May 17th 2017 from 05:30am to 06:30am (GMT+2)
Reykjavik : Wednesday, May 17th 2017 from 08:30am to 09:30am (GMT+2)
London / Dublin : Wednesday, May 17th 2017 from 09:30am to 10:30am (GMT+2)
Paris / Berlin : Wednesday, May 17th 2017 from 10:30am to 11:30am (GMT+2)
Istanbul : Wednesday, May 17th 2017 from 11:30am to 12:30pm (GMT+2)
Moscou / Dubaï : Wednesday, May 17th 2017 from 12:30pm to 01:30pm (GMT+2)
Bangkok : Wednesday, May 17th 2017 from 03:30pm to 04:30pm (GMT+2)
Shanghai : Wednesday, May 17th 2017 from 04:30pm to 05:30pm (GMT+2)
Tokyo : Wednesday, May 17th 2017 from 05:30pm to 06:30pm (GMT+2)
Sydney : Wednesday, May 17th 2017 from 07:30pm to 08:30pm (GMT+2)
Wellington : Wednesday, May 17th 2017 from 09:30pm to 10:30pm (GMT+2)
Discussion around complex PCI
How to deal with complications?
Share
Monday, October 30th 2023 from 05pm to 06pm (GMT+1)
Honolulu : Monday, October 30th 2023 from 05am to 06am (GMT+1)
San Francisco : Monday, October 30th 2023 from 07am to 08am (GMT+1)
New York : Monday, October 30th 2023 from 10am to 11am (GMT+1)
Buenos Aires : Monday, October 30th 2023 from 12pm to 01pm (GMT+1)
London / Dublin : Monday, October 30th 2023 from 03pm to 04pm (GMT+1)
Paris / Berlin : Monday, October 30th 2023 from 04pm to 05pm (GMT+1)
Istanbul : Monday, October 30th 2023 from 05pm to 06pm (GMT+1)
Moscou / Dubaï : Monday, October 30th 2023 from 07pm to 08pm (GMT+1)
Bangkok : Monday, October 30th 2023 from 10pm to 11pm (GMT+1)
Shanghai : Monday, October 30th 2023 from 11pm to 12am (GMT+1)
Tokyo : Tuesday, October 31st 2023 from 12am to 01am (GMT+1)
Sydney : Tuesday, October 31st 2023 from 01am to 02am (GMT+1)
Wellington : Tuesday, October 31st 2023 from 03am to 04am (GMT+1)
San Francisco : Monday, October 30th 2023 from 07am to 08am (GMT+1)
New York : Monday, October 30th 2023 from 10am to 11am (GMT+1)
Buenos Aires : Monday, October 30th 2023 from 12pm to 01pm (GMT+1)
London / Dublin : Monday, October 30th 2023 from 03pm to 04pm (GMT+1)
Paris / Berlin : Monday, October 30th 2023 from 04pm to 05pm (GMT+1)
Istanbul : Monday, October 30th 2023 from 05pm to 06pm (GMT+1)
Moscou / Dubaï : Monday, October 30th 2023 from 07pm to 08pm (GMT+1)
Bangkok : Monday, October 30th 2023 from 10pm to 11pm (GMT+1)
Shanghai : Monday, October 30th 2023 from 11pm to 12am (GMT+1)
Tokyo : Tuesday, October 31st 2023 from 12am to 01am (GMT+1)
Sydney : Tuesday, October 31st 2023 from 01am to 02am (GMT+1)
Wellington : Tuesday, October 31st 2023 from 03am to 04am (GMT+1)
How do the new antithrombotic recommendations affect your HBR patients?
Gain insights from a patient case analysis
Share
Thursday, June 1st 2023 from 05pm to 06pm (GMT+2)
Honolulu : Thursday, June 1st 2023 from 05am to 06am (GMT+2)
San Francisco : Thursday, June 1st 2023 from 08am to 09am (GMT+2)
New York : Thursday, June 1st 2023 from 11am to 12pm (GMT+2)
Buenos Aires : Thursday, June 1st 2023 from 12pm to 01pm (GMT+2)
Reykjavik : Thursday, June 1st 2023 from 03pm to 04pm (GMT+2)
London / Dublin : Thursday, June 1st 2023 from 04pm to 05pm (GMT+2)
Paris / Berlin : Thursday, June 1st 2023 from 05pm to 06pm (GMT+2)
Istanbul : Thursday, June 1st 2023 from 06pm to 07pm (GMT+2)
Moscou / Dubaï : Thursday, June 1st 2023 from 07pm to 08pm (GMT+2)
Bangkok : Thursday, June 1st 2023 from 10pm to 11pm (GMT+2)
Shanghai : Thursday, June 1st 2023 from 11pm to 12am (GMT+2)
Tokyo : Friday, June 2nd 2023 from 12am to 01am (GMT+2)
Sydney : Friday, June 2nd 2023 from 02am to 03am (GMT+2)
Wellington : Friday, June 2nd 2023 from 04am to 05am (GMT+2)
San Francisco : Thursday, June 1st 2023 from 08am to 09am (GMT+2)
New York : Thursday, June 1st 2023 from 11am to 12pm (GMT+2)
Buenos Aires : Thursday, June 1st 2023 from 12pm to 01pm (GMT+2)
Reykjavik : Thursday, June 1st 2023 from 03pm to 04pm (GMT+2)
London / Dublin : Thursday, June 1st 2023 from 04pm to 05pm (GMT+2)
Paris / Berlin : Thursday, June 1st 2023 from 05pm to 06pm (GMT+2)
Istanbul : Thursday, June 1st 2023 from 06pm to 07pm (GMT+2)
Moscou / Dubaï : Thursday, June 1st 2023 from 07pm to 08pm (GMT+2)
Bangkok : Thursday, June 1st 2023 from 10pm to 11pm (GMT+2)
Shanghai : Thursday, June 1st 2023 from 11pm to 12am (GMT+2)
Tokyo : Friday, June 2nd 2023 from 12am to 01am (GMT+2)
Sydney : Friday, June 2nd 2023 from 02am to 03am (GMT+2)
Wellington : Friday, June 2nd 2023 from 04am to 05am (GMT+2)
The safe use of DCB in PCI:
from young to old patients
Share
Alexander P. Why DES in distal LAD ? BVS Absorb?
Daniel W. Hi Alexander. Thank you for your question. We know from the Absorb data that scaffolds perform worse than DES in smaller vessels, associated with a higher MACE rate. An alternative could be treating small vessels with DCB. The BASKET small study result will be presented in 2018 (DES vs DCB in small vessels). DCB are good in our experience when you have TIMI flow III, no more than a dissection A or B, and less than 30% residual stenosis.